Lung Cancer Therapy
Researchers at Tianjin Medical University, Cancer Institute publish new data on lung cancer therapy
Published in Cancer Weekly, August 7th, 2007
A new study, "CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients," is now available. According to recent research published in the Journal of Clinical Immunology, "CD(4) (+)CD(25) (+) regulatory T cells (Tregs) have been shown to inhibit cytotoxic lymphocytes-mediated immune responses. Cytokine-induced killer (CIK) cells exert high impact on adoptive immunotherapeutic approaches."
"Therefore, the purpose of this report was to determine the effect of Tregs on CIK cell growth and CIK-induced cytotoxicity for inhibition of tumor growth in vivo as well as in vitro. After depletion of CD(4)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-08-07)
More Articles from Cancer Weekly
- Cancer Gene Therapy
"Preconditioning" Helps Protect Brain's Blood Vessels from Stroke - Cancer Gene Therapy
Pediatric Ritalin Use May Affect Developing Brain - Cancer Vaccines
Gene-Transcription Machinery Seen Poised for Action, Held in Check Until Needed - Bladder Cancer
Pro-Pharmaceuticals Announces Boston Medical Center Dosing Patients with DAVANAT in Advanced Biliary Cancer Trial - Brain Cancer
A Substantial Opportunity Exists for Second-Line Chemotherapy to Enter the Primary Brain Cancer Market - Breast Cancer
American Medical Association Approves CPT Code for Electronic Brachytherapy for Treatment of Early Breast Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
